Interventional Cardiologists Nico Pijls, Bernard De Bruyne to Discuss Congress 2007

    EBAC-Accredited Workshop Set for Sept. 3

    UPPSALA, Sweden and WILMINGTON, Mass., Aug. 31 /CNW/ -- Nico Pijls, M.D.,
Ph.D., and Bernard de Bruyne, M.D., Ph.D., will present the benefits of
measuring coronary pressure, or Fractional Flow Reserve (FFR), in improving
the outcomes of multivessel PCI in a workshop at the European Society of
Cardiology (ESC) Congress 2007 in Vienna.  The EBAC-accredited workshop, which
is sponsored by Radi Medical Systems, will take place at 12:45 p.m. CEST on
Monday, Sept. 3, in the Copenhagen Room in Zone 1 of the Messe Wien Conference
    Dr. Pijls, of the department of cardiology at Catharina Hospital in
Eindhoven, the Netherlands, will cover "Assessment Of Ischaemia In The
Cathlab: The Best And Easiest Way To Go." Dr. de Bruyne, with the
Cardiovascular Center Aalst in Aalst, Belgium, will explore the "Diagnosis And
Treatment Of Multivessel Disease: All In One." Both physicians were
investigators in the DEFER study, which evaluated the appropriateness of
stenting a coronary stenosis (abnormal narrowing) that appears to be
angiographically significant but is not restricting blood flow enough to cause
symptoms.  Five-year results were published in the May 29 issue of the Journal
of the American College of Cardiology.
    About FFR
    FFR expresses maximum achievable blood flow in a coronary artery with
abnormal stenosis as a fraction of normal maximum blood flow in the absence of
a stenosis. It is calculated using an interventional guidewire with a
specially designed sensor built into it. Using the well established value of
0.75, FFR is 100% specific in identifying which lesions are actually causing
flow restriction and can be treated. FFR also documents the exact percentage
of the reduction in flow associated with each lesion.
    About Radi Medical Systems AB
    Radi Medical Systems AB (Radi) develops, manufactures and sells medical
devices designed to improve patient care. The company's pioneering work in the
field of interventional cardiology has resulted in market-leading
intravascular sensors and hemostasis management and radiology devices. Radi
works closely with medical practitioners to develop solutions that address
clinical needs, as well as provide clinical education support. Founded in
1988, Radi employs more than 350 people globally and has representation in
more than 40 countries. The company is based in Uppsala, Sweden, and maintains
a U.S. headquarters in Wilmington, Mass. For more information, visit

    Media Contacts:

    David Schull or Benjamin Carmichael
    Russo Partners LLC
    +1 212-845-4271

    Jim Archetto
    Radi Medical Systems Inc.
    +1 877-337-7234 x812

For further information:

For further information: David Schull,, or Benjamin Carmichael,, both of Russo Partners LLC for Radi 
Medical Systems Inc., +1-212-845-4271; or Jim Archetto of Radi Medical Systems
 Inc., +1-877-337-7234 x812, Web Site:

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890